Sclerostin was expressed in 3D constructs that activated the nuclear factor κ B/osteoprotegerin (RANK/OPG) pathway of prostate cancer cells, affecting the nuclear factor κ B/osteoprotegerin (RANK/OPG) pathway of prostate cancer cells, affecting the nuclear factor κ B/osteoprotegerin (RANK/OPG) pathway of prostate cancer cells affecting metastasis. Here, SOST is linked to prostate carcinoma.